These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21426160)

  • 1. Computer tools in the discovery of HIV-1 integrase inhibitors.
    Liao C; Nicklaus MC
    Future Med Chem; 2010 Jul; 2(7):1123-40. PubMed ID: 21426160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authentic HIV-1 integrase inhibitors.
    Liao C; Marchand C; Burke TR; Pommier Y; Nicklaus MC
    Future Med Chem; 2010 Jul; 2(7):1107-22. PubMed ID: 21426159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
    Nair V
    Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
    Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
    Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW
    J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 integrase inhibition: looking at cofactor interactions.
    Christ F; Debyser Z
    Future Med Chem; 2015; 7(18):2407-10. PubMed ID: 26669900
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV integrase: a target for drug discovery.
    Lutzke RA; Plasterk RH
    Genes Funct; 1997 Dec; 1(5-6):289-307. PubMed ID: 17366700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
    Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the development of HIV integrase strand transfer inhibitors.
    Wang Y; Gu SX; He Q; Fan R
    Eur J Med Chem; 2021 Dec; 225():113787. PubMed ID: 34425310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay.
    Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A
    Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.